CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 111 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,889,000 | -31.5% | 2,124,975 | 0.0% | 0.07% | -23.9% |
Q1 2022 | $5,674,000 | -59.2% | 2,124,975 | -33.9% | 0.09% | -48.6% |
Q4 2021 | $13,919,000 | +50.1% | 3,214,509 | +76.4% | 0.18% | +75.5% |
Q3 2021 | $9,273,000 | -3.2% | 1,821,868 | +20.4% | 0.10% | +5.2% |
Q2 2021 | $9,578,000 | – | 1,513,168 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 6,450,000 | $8,320,500 | 1.17% |
BVF INC/IL | 6,595,801 | $8,508,583 | 0.23% |
Bronte Capital Management Pty Ltd. | 925,245 | $1,193,566 | 0.12% |
Formidable Asset Management, LLC | 318,111 | $410,363 | 0.09% |
Congress Park Capital LLC | 112,450 | $145,061 | 0.08% |
Forefront Analytics, LLC | 49,421 | $63,754 | 0.04% |
Ground Swell Capital, LLC | 10,966 | $14,146 | 0.02% |
Clearline Capital LP | 196,583 | $253,592 | 0.02% |
CORNERCAP INVESTMENT COUNSEL INC | 81,352 | $104,944 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 2,646,190 | $3,412 | 0.01% |